neuroendocrine tumors

You have access
Somatostatin Receptor 2–Targeting Compounds
Daan A. Smit Duijzentkunst, Dik J. Kwekkeboom and Lisa Bodei

Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 54S-60S; DOI: https://doi.org/10.2967/jnumed.117.191015
You have access
Somatostatin Receptor Antagonists for Imaging and Therapy
Melpomeni Fani, Guillaume P. Nicolas and Damian Wild

Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 61S-66S; DOI: https://doi.org/10.2967/jnumed.116.186783
You have access
Parametric Net Influx Rate Images of ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE: Quantitative Accuracy and Improved Image Contrast
Ezgi Ilan, Mattias Sandström, Irina Velikyan, Anders Sundin, Barbro Eriksson and Mark Lubberink

Journal of Nuclear Medicine May 1, 2017, 58 (5) 744-749; DOI: https://doi.org/10.2967/jnumed.116.180380
You have access
Head-to-Head Comparison of ⁶⁴Cu-DOTATATE and ⁶⁸Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors
Camilla B. Johnbeck, Ulrich Knigge, Annika Loft, Anne K. Berthelsen, Jann Mortensen, Peter Oturai, Seppo W. Langer, Dennis R. Elema and Andreas Kjaer

Journal of Nuclear Medicine March 1, 2017, 58 (3) 451-457; DOI: https://doi.org/10.2967/jnumed.116.180430
You have access
Comparison of the Impact of ⁶⁸Ga-DOTATATE and ¹⁸F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors
Emmanouil Panagiotidis, Alshaima Alshammari, Sofia Michopoulou, Evangelia Skoura, Keval Naik, Emmanouil Maragkoudakis, Mullan Mohmaduvesh, Mohammed Al-Harbi, Maria Belda, Martyn E. Caplin, Christos Toumpanakis and Jamshed Bomanji

Journal of Nuclear Medicine January 1, 2017, 58 (1) 91-96; DOI: https://doi.org/10.2967/jnumed.116.178095
You have access
Upregulation of Key Molecules for Targeted Imaging and Therapy
Vincent F. Taelman, Piotr Radojewski, Nicolas Marincek, Anat Ben-Shlomo, Andrea Grotzky, Cristina I. Olariu, Aurel Perren, Christoph Stettler, Thomas Krause, Lorenz P. Meier, Renzo Cescato and Martin A. Walter

Journal of Nuclear Medicine November 1, 2016, 57 (11) 1805-1810; DOI: https://doi.org/10.2967/jnumed.115.165092
You have access
Evaluation of a Fluorescent and Radiolabeled Hybrid Somatostatin Analog In Vitro and in Mice Bearing H69 Neuroendocrine Xenografts
Costanza Santini, Joeri Kuil, Anton Bunschoten, Stefan Pool, Erik de Blois, Yanto Ridwan, Jeroen Essers, Monique R. Bernsen, Fijs W.B. van Leeuwen and Marion de Jong

Journal of Nuclear Medicine August 1, 2016, 57 (8) 1289-1295; DOI: https://doi.org/10.2967/jnumed.115.164970
You have access
The Impact of ⁶⁸Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom
Evangelia Skoura, Sofia Michopoulou, Mullan Mohmaduvesh, Emmanouil Panagiotidis, Mohammed Al Harbi, Christos Toumpanakis, Omar Almukhailed, Irfan Kayani, Rizwan Syed, Shaunak Navalkissoor, Peter J. Ell, Martyn E. Caplin and Jamshed Bomanji

Journal of Nuclear Medicine January 1, 2016, 57 (1) 34-40; DOI: https://doi.org/10.2967/jnumed.115.166017
You have access
Time Evolution of DOTATOC Uptake in Neuroendocrine Tumors in View of a Possible Application of Radioguided Surgery with β⁻ Decay
Francesco Collamati, Fabio Bellini, Valerio Bocci, Erika De Lucia, Valentina Ferri, Federica Fioroni, Elisa Grassi, Mauro Iori, Michela Marafini, Silvio Morganti, Riccardo Paramatti, Vincenzo Patera, Luigi Recchia, Andrea Russomando, Alessio Sarti, Adalberto Sciubba, Martina Senzacqua, Elena Solfaroli Camillocci, Annibale Versari, Cecilia Voena and Riccardo Faccini

Journal of Nuclear Medicine October 1, 2015, 56 (10) 1501-1506; DOI: https://doi.org/10.2967/jnumed.115.160481
You have access
⁶⁴Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with ¹¹¹In-DTPA-Octreotide in 112 Patients
Andreas Pfeifer, Ulrich Knigge, Tina Binderup, Jann Mortensen, Peter Oturai, Annika Loft, Anne Kiil Berthelsen, Seppo W. Langer, Palle Rasmussen, Dennis Elema, Eric von Benzon, Liselotte Højgaard and Andreas Kjaer

Journal of Nuclear Medicine June 1, 2015, 56 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.115.156539

Main menu

User menu

Search

neuroendocrine tumors

Pages